Fig. 8: The schematic diagram of LINC00941 promoting pancreatic cancer progression.

LINC00941 acts as a decoy to interact with ANXA2, blocking the key interaction domain between NEDD4L and ANXA2, inhibiting ubiquitin-mediated degradation of ANXA2. Eventually, LINC00941 stabilizes ANXA2 and promotes activation of FAK/AKT signaling, resulting in facilitating pancreatic cancer proliferation, migration, and invasion (the figure was drawn by Figdraw, ID:UPATW888a4).